Strategies have been explored to reduce side effects and enhance anti-tumor effects, such as coupling drugs with antibodies, preparing a “biological bomb” with human albumin or PEG, enhancing drug solubility, reducing the removal efficiency of drugs via blood, or preparing drugs into nanoparticles (Maluccio & Covey, 2012) for the use in cancer therapy by intravenous injection. Here, ALB is linked to cancer.